UK Companies House feature
NOVO NORDISK HOLDING LIMITED
Profile
- Company number
- 01329008
- Status
- Active
- Incorporation
- 1977-09-07
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 21100
- Hubs
- UK Healthcare
Accounts
Pending extraction
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have reviewed the company's and its subsidiary's projected profits and cash flows. After having examined the likely developments in the foreseeable future, the directors have a reasonable expectation that the.company and its subsidiary have adequate resources to continue in operational existence, being at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the annual report and financial statements.”
Subsidiaries
- Novo Nordisk Limited · 100% held · England · Marketing and distribution of pharmaceutical and related products, and basic R&D on multiple therapy areas
Significant events
- “Since November 2020, we have transitioned our fleet of 350 vehicles from internal combustion engines to fully electric (EV) and plug-in hybrid electric (PHEV) vehicles. In 2024, the average CO2 emissions per vehicle were 13.8g/km. We plan to phase out PHEV vehicles and transition to an entirely EV fleet by 31st May 2025.”
- “In 2024, 550,000 pens were successfully returned from the UK for recycling.”
- “The Group has set targets for all its affiliates, including the Company, to align with the Group's Circular for Zero strategy: 1. Source 100% renewable power by 2030. By the end of 2024, the energy supply for both offices and EV charging points was entirely from renewable sources. 2. Ensure all company cars are EV or PHEV by 2025 - this target will be achieved by the end of March 2025 for the Company. 3. Achieve zero CO2 emissions from flights by 2030.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 17 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| ABOGADO NOMINEES LIMITED | Corporate Nominee Secretary | 1992-11-04 | — | — |
| LARSEN, Jonas Emil Kongshoj | Director | 2023-01-27 | Sep 1975 | Danish |
| NIELSEN, Thomas Rask | Director | 2024-04-29 | Jul 1970 | Danish |
Show 17 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BAILEY, Nicholas James | Secretary | 2011-02-16 | 2012-05-01 |
| BROWN, Stephen Lawrence | Secretary | — | 1999-10-14 |
| LLOYD GOODWIN, Wendy Helen | Secretary | 2009-05-18 | 2011-02-16 |
| O'FLYNN, Matthew | Secretary | 2012-05-01 | 2024-10-15 |
| ROBERTS, Sandra | Secretary | 1999-10-15 | 2009-05-18 |
| WINTER, David | Secretary | — | 1993-06-23 |
| BRANDGAARD, Jesper | Director | 2000-11-14 | 2019-04-12 |
| BYFELDT, Hans | Director | — | 1994-06-01 |
| HAAGEN, Tomas | Director | 2018-11-20 | 2024-04-29 |
| KIER, Frederik | Director | 2020-07-28 | 2022-11-18 |
| NIELSEN, Kurt Anker | Director | 1998-12-01 | 2000-11-14 |
| OVESEN, Jesper | Director | 1996-04-15 | 1998-12-01 |
| RAMSBY, Ole Falvig | Director | 1997-06-18 | 2018-11-20 |
| REGAN, Matt Joseph | Director | 2017-11-16 | 2020-07-03 |
| SORENSEN, Erik | Director | — | 1996-04-15 |
| SORENSEN, Jakob | Director | 1995-04-24 | 1997-04-30 |
| SORENSEN, Mads Ravn | Director | — | 1996-04-15 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Novo Nordisk A/S | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 172 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-06-26 | AD02 | address | change sail address company with old address new address |
| 2025-06-25 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-06-19 | AA | accounts | accounts with accounts type full |
| 2024-10-15 | TM02 | officers | termination secretary company with name termination date |
| 2024-06-27 | CH04 | officers | change corporate secretary company with change date |
| 2024-06-27 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-06-27 | AD02 | address | change sail address company with old address new address |
| 2024-06-25 | AA | accounts | accounts with accounts type full |
| 2024-05-01 | AP01 | officers | appoint person director company with name date |
| 2024-05-01 | TM01 | officers | termination director company with name termination date |
| 2023-09-28 | AA | accounts | accounts with accounts type full |
| 2023-06-27 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-02-02 | AP01 | officers | appoint person director company with name date |
| 2023-02-02 | TM01 | officers | termination director company with name termination date |
| 2022-10-07 | AA | accounts | accounts with accounts type full |
| 2022-07-05 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-08-14 | AA | accounts | accounts with accounts type full |
| 2021-07-02 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2020-10-05 | AA | accounts | accounts with accounts type full |
| 2020-08-03 | AP01 | officers | appoint person director company with name date |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory